Holen Sie sich die Stockscreener-App
6.96
2.21%
0.16
Handel nachbörslich:
6.94
-0.02
-0.29%
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
5.19%
8.699
|
9.175 | 83.75 | -7.676 | 19.69 |
Operating Expenses
|
4.20%
61.46
|
58.98 | 60.78 | 56.24 | 54.69 |
| Benefits Costs and Expenses |
5.56%
59.17
|
56.05 | 54.49 | 54.10 | 52.62 |
| Costs And Expenses |
5.56%
59.17
|
56.05 | 47.39 | 56.24 | 52.62 |
| Operating Income/Loss |
5.93%
-52.76
|
-49.80 | 22.97 | -63.91 | -35.00 |
| Nonoperating Income/Loss |
21.74%
2.29
|
2.926 | 6.286 | 2.135 | 2.074 |
| Income/Loss From Continuing Operations Before Tax |
7.66%
-50.47
|
-46.88 | 29.25 | -61.78 | -32.92 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
7.66%
-50.47
|
-46.88 | 29.25 | -61.78 | -32.92 |
|
Net Income/Loss
|
7.66%
-50.47
|
-46.88 | 29.25 | -61.78 | -32.92 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.90%
163.99
|
162.53 | 7.8069 | 132.56 | 129.53 |
| Diluted Average Shares |
0.90%
163.99
|
162.53 | 7.8069 | 132.56 | 129.53 |
| Basic Earnings Per Share |
6.90%
-0.31
|
-0.29 | 0.27 | -0.47 | -0.25 |
| Diluted Earnings Per Share |
6.90%
-0.31
|
-0.29 | 0.27 | -0.47 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.25%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):